(Q42923039)

English

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

scientific article published on 29 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (English)

1 reference

Europe PubMed Central

11 November 2017

atrial fibrillation

0 references

Paulus Kirchhof

4

1 reference

Europe PubMed Central

11 November 2017

17

1 reference

Europe PubMed Central

11 November 2017

27

object named as

Frans H Rutten

1 reference

Europe PubMed Central

11 November 2017

Piotr Ponikowski

object named as

Piotr Ponikowski

26

0 references

5

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

11 November 2017

16

object named as

Dan Atar

1 reference

Europe PubMed Central

11 November 2017

Gerhard Hindricks

11

object named as

Gerhard Hindricks

1 reference

Europe PubMed Central

11 November 2017

European Heart Rhythm Association

1

object named as

European Heart Rhythm Association

1 reference

Europe PubMed Central

11 November 2017

Isabelle C Van Gelder

9

object named as

Isabelle C Van Gelder

1 reference

Europe PubMed Central

11 November 2017

24

object named as

Philippe Kolh

1 reference

Europe PubMed Central

11 November 2017

20

object named as

Andreas Goette

1 reference

Europe PubMed Central

11 November 2017

Hein Heidbuchel

13

object named as

Hein Heidbuchel

1 reference

Europe PubMed Central

11 November 2017

Ulrich Schotten

6

object named as

Ulrich Schotten

1 reference

Europe PubMed Central

11 November 2017

21

object named as

Bulent Gorenek

1 reference

Europe PubMed Central

11 November 2017

Jean-Yves Le Heuzey

25

object named as

Jean-Yves Le Heuzey

1 reference

Europe PubMed Central

11 November 2017

Raffaele De Caterina

18

object named as

Raffaele De Caterina

1 reference

Europe PubMed Central

11 November 2017

3

object named as

A John Camm

1 reference

Europe PubMed Central

11 November 2017

Nawwar Al-Attar

10

object named as

Nawwar Al-Attar

1 reference

Europe PubMed Central

11 November 2017

Irene Savelieva

7

object named as

Irene Savelieva

1 reference

Europe PubMed Central

11 November 2017

8

object named as

Sabine Ernst

1 reference

Europe PubMed Central

11 November 2017

Bernard D Prendergast

12

object named as

Bernard Prendergast

1 reference

Europe PubMed Central

11 November 2017

Ottavio Alfieri

14

object named as

Ottavio Alfieri

1 reference

Europe PubMed Central

11 November 2017

22

object named as

Magnus Heldal

1 reference

Europe PubMed Central

11 November 2017

Stefan H. Hohloser

23

object named as

Stefan H Hohloser

1 reference

Europe PubMed Central

11 November 2017

Johan De Sutter

19

object named as

Johan De Sutter

1 reference

Europe PubMed Central

11 November 2017

author name string

European Association for Cardio-Thoracic Surgery

2

1 reference

Europe PubMed Central

11 November 2017

Annalisa Angelini

15

1 reference

Europe PubMed Central

11 November 2017

publication date

29 August 2010

1 reference

Europe PubMed Central

11 November 2017

European Heart Journal

1 reference

Europe PubMed Central

11 November 2017

31

1 reference

Europe PubMed Central

11 November 2017

2369-2429

1 reference

Europe PubMed Central

11 November 2017

19

1 reference

Europe PubMed Central

11 November 2017

Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Outcome parameters for trials in atrial fibrillation: executive summary

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Increasing prevalence of atrial fibrillation and flutter in the United States

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of atrial fibrillation on atrial refractoriness in humans.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Sodium channel mutations and susceptibility to heart failure and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

KCNQ1 gain-of-function mutation in familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardi

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Comparison of continuous versus intermittent monitoring of atrial arrhythmias.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Indications for the use of diagnostic implantable and external ECG loop recorders

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone versus sotalol for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Soc

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Rhythm control versus rate control for atrial fibrillation and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Catheter ablation for atrial fibrillation in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Lenient versus strict rate control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of medications in Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Evidence-based analysis of amiodarone efficacy and safety

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Increased mortality after dronedarone therapy for severe heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Consensus document on antithrombotic therapy in the setting of electrophysiological procedures

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Successful surgical treatment of atrial fibrillation. Review and clinical update

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Surgical approaches to atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Valsartan for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Cardiac resynchronization therapy in heart failure patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Relation of vigorous exercise to risk of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-lasting sport practice and lone atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Management of atrial fibrillation in the post-cardiac surgery setting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A multicenter risk index for atrial fibrillation after cardiac surgery

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A Randomized Study of Prophylactic Catheter Ablation in Asymptomatic Patients with the Wolff–Parkinson–White Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablatio

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHQ278

1 reference

Europe PubMed Central

11 November 2017

release_ivt52khpgzh47d4qmbfwyd45qi

1 reference

https://api.fatcat.wiki/v0/release/ivt52khpgzh47d4qmbfwyd45qi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42923039&oldid=1838654154"